Phenotypic Tolerance: Antibiotic Enrichment of Noninherited Resistance in Bacterial Populations

ABSTRACT When growing bacteria are exposed to bactericidal concentrations of antibiotics, the sensitivity of the bacteria to the antibiotic commonly decreases with time, and substantial fractions of the bacteria survive. Using Escherichia coli CAB1 and antibiotics of five different classes (ampicillin, ciprofloxacin, rifampin, streptomycin, and tetracycline), we examine the details of this phenomenon and, with the aid of mathematical models, develop and explore the properties and predictions of three hypotheses that can account for this phenomenon: (i) antibiotic decay, (ii) inherited resistance, and (iii) phenotypic tolerance. Our experiments cause us to reject the first two hypotheses and provide evidence that this phenomenon can be accounted for by the antibiotic-mediated enrichment of subpopulations physiologically tolerant to but genetically susceptible to these antibiotics, phenotypic tolerance. We demonstrate that tolerant subpopulations generated by exposure to one concentration of an antibiotic are also tolerant to higher concentrations of the same antibiotic and can be tolerant to antibiotics of the other four types. Using a mathematical model, we explore the effects of phenotypic tolerance to the microbiological outcome of antibiotic treatment and demonstrate, a priori, that it can have a profound effect on the rate of clearance of the bacteria and under some conditions can prevent clearance that would be achieved in the absence of tolerance.

[1]  A. Tomasz,et al.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. , 1986, Journal of general microbiology.

[2]  J. Lobry,et al.  Biphasic kinetics of bacterial killing by quinolones. , 1991, Journal of Antimicrobial Chemotherapy.

[3]  J. Libby Postantibiotic Effect in Escherichia coli Determined with Real-Time Metabolic Monitoring , 1998, Antimicrobial Agents and Chemotherapy.

[4]  B. Levin,et al.  The population dynamics of antimicrobial chemotherapy , 1997, Antimicrobial agents and chemotherapy.

[5]  C. Bloch,et al.  Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12 , 1996, Infection and immunity.

[6]  J. Flandrois,et al.  Mathematical model for comparison of time-killing curves , 1993, Antimicrobial Agents and Chemotherapy.

[7]  S. Zinner,et al.  Prediction of the Effects of Inoculum Size on the Antimicrobial Action of Trovafloxacin and Ciprofloxacin againstStaphylococcus aureus and Escherichia coli in an In Vitro Dynamic Model , 1999, Antimicrobial Agents and Chemotherapy.

[8]  Roland R. Regoes,et al.  Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens , 2004, Antimicrobial Agents and Chemotherapy.

[9]  J. Schwartz,et al.  The vir locus affects the response of Bordetella pertussis to antibiotics: phenotypic tolerance and control of autolysis. , 1990, The Journal of infectious diseases.

[10]  A. Tomasz,et al.  Antibiotic tolerance among clinical isolates of bacteria , 1986, Antimicrobial Agents and Chemotherapy.

[11]  R. Wise,et al.  Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. , 1986, The Journal of antimicrobial chemotherapy.

[12]  C. Bloch,et al.  Dynamics of success and failure in phage and antibiotic therapy in experimental infections , 2002, BMC Microbiology.

[13]  K. Lewis,et al.  Persister cells and tolerance to antimicrobials. , 2004, FEMS microbiology letters.

[14]  C. Wa,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990 .

[15]  K. Bowker,et al.  A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone. , 1996, The Journal of antimicrobial chemotherapy.

[16]  H Derendorf,et al.  A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. , 2000, The Journal of antimicrobial chemotherapy.

[17]  A. Tomasz,et al.  Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[18]  G. Jackson,et al.  First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use , 1991, Antimicrobial Agents and Chemotherapy.

[19]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[20]  Stanley N Cohen,et al.  SOS Response Induction by ß-Lactams and Bacterial Defense Against Antibiotic Lethality , 2004, Science.

[21]  K. Lewis,et al.  Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli , 2004, Journal of bacteriology.

[22]  A. Bayer,et al.  Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model , 1997, Antimicrobial agents and chemotherapy.

[23]  Jeffrey W. Smith,et al.  Stochastic Gene Expression in a Single Cell , 2022 .

[24]  W. Craig,et al.  Pharmacokinetic/pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men Tions Were Associated with Only a Slight Reduction in Bacterial , 2022 .

[25]  T. Raivio Faculty Opinions recommendation of SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. , 2004 .

[26]  C. Bloch,et al.  General method for site-directed mutagenesis in Escherichia coli O18ac:K1:H7: deletion of the inducible superoxide dismutase gene, sodA, does not diminish bacteremia in neonatal rats , 1989, Infection and immunity.

[27]  L. Valera,et al.  Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents , 2000, Antimicrobial Agents and Chemotherapy.

[28]  M. Barclay,et al.  Aminoglycoside adaptive resistance: importance for effective dosage regimens. , 2001, Drugs.

[29]  D. Schiemann An unstable small-colony variant of a noninvasive mutant of Salmonella typhimurium is highly invasive for MDCK cells. , 1995, FEMS microbiology letters.

[30]  J. Vilar,et al.  From molecular noise to behavioural variability in a single bacterium , 2004, Nature.

[31]  E. Tuomanen,et al.  Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae , 1996, Infection and immunity.

[32]  R. Proctor,et al.  A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly , 1997, Journal of bacteriology.

[33]  E. Tuomanen Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. , 1986, Reviews of infectious diseases.

[34]  G. Cornaglia,et al.  MIC-Based Interspecies Prediction of the Antimicrobial Effects of Ciprofloxacin on Bacteria of Different Susceptibilities in an In Vitro Dynamic Model , 1998, Antimicrobial Agents and Chemotherapy.

[35]  J. Karlowsky,et al.  In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa , 1996, Antimicrobial agents and chemotherapy.

[36]  Hartmut Derendorf,et al.  Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC , 2004, Antimicrobial Agents and Chemotherapy.

[37]  R. Mei,et al.  Killing by Ampicillin and Ofloxacin Induces Overlapping Changes in Escherichia coli Transcription Profile , 2004, Antimicrobial Agents and Chemotherapy.

[38]  W. Craig,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[39]  L. Amaral,et al.  The post-antibiotic effect defined by bacterial morphology. , 1989, The Journal of antimicrobial chemotherapy.

[40]  M. Barclay,et al.  Adaptive resistance following single doses of gentamicin in a dynamic in vitro model , 1992, Antimicrobial Agents and Chemotherapy.

[41]  G. Jackson,et al.  Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. , 1990, The Journal of infectious diseases.